iKnowMed Generation 2 — Chart Summary

Clinical Notes & Other Documents

06/19/2026 - Cycle 5 — FOLFOX + Bevacizumab - Rao, Priya, MD

06/05/2026 - Cycle 4 — FOLFOX + Bevacizumab - Rao, Priya, MD

05/14/2026 - Restaging review - Rao, Priya, MD

02/24/2026 - New patient consult — mCRC - Rao, Priya, MD

Messages

07/02/2026 - Nurse triage: cold-sensitivity / neuropathy question - Alvarez, Linda

Vital Signs

07/06/2026 08:10 AM - Ht: 62 (in) Wt: 140 (lb) BSA 1.68 m2 BP 152/94 BP elevated vs. baseline (bevacizumab).

Results

07/06/2026 - CEA 8.1 ng/mL (was 42.0 baseline) · ANC 1.3 · Hgb 10.4 · Plt 118

Treatment Events

07/06/2026 - Cycle 6 deferred one week (ANC 1.3) — recheck CBC

1 other Treatment event outside this interval - Show All

Active Regimens

5-FU + Leucovorin + Oxaliplatin (FOLFOX) + Bevacizumab IV Q14D Cycle Length: 14 Number Cycles: 12 Start: C1D1 on 04/24/2026 Assoc Dx: Colon cancer, metastatic LOT: First-line

Depression Status

06/19/2026 - PHQ-2 screen negative. No further action indicated.

i Document

iKnowMed G2 note template ready — awaiting documentation from Commure Ambient

Simulated iKnowMed Generation 2 view for Commure Ambient integration demos · Not affiliated with Ontada or McKesson. Section labels shown carry the published iKnowMed G2 writeback codes (LOINC / g2.docsections.org).